Close menu

 

  • In response to the growing demand for capabilities for increasingly complex and more potent Active Pharmaceutical Ingredients (APIs), this new cGMP(current Good Manufacturing Practices) production unit reinforces Axplora’s position as the partner of choice in large scale manufacturing for Highly Potent Active Pharmaceutical Ingredients (HPAPIs) and Steroids, as well as for Generics and CDMO services.
  • The versatile and modular facility is a vertical-designed building, composed of 4 floors with a 2,800 m² total area, including space for future cGMP capacity expansion.
  • This multi-purpose facility produces batches up to 300 kg in size with state-of-the-art technologies and equipment.

 

Read the press release

More information